Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

EF Hutton Maintains Buy on Hour Loop, Lowers Price Target to $5

EF Hutton analyst Ben Piggott maintains Hour Loop (NASDAQ:HOUR) with a Buy and lowers the price target from $7 to $5.
byBenzinga Newsdesk
August 16, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

EF Hutton analyst Ben Piggott maintains Hour Loop (NASDAQ:HOUR) with a Buy and lowers the price target from $7 to $5.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Incyte Announced Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nonsegmental Vitiligo; Said Patients Treated With Povorcitinib Experienced Improvements In Total Body And Facial Repigmentation

By Charles Gross
March 18, 3:51 PM
Incyte (Nasdaq: INCY) today announced new data from a Phase 2b clinical trial evaluating the safety and efficacy of povorcitinib (INCB54707), an investigational oral JAK1 inhibitor, in adult patients with extensive nonsegmental vitiligo.

INCY